Citigate Dewe Rogerson
Highly Engaged Employees
Highly Engaged EmployeesAdvertising Networks · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
41-44 Great Windmill St, London, Greater...Phone Number
+44 2070256400Website
www.citigatedewerogerson.comRevenue
$28.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Citigate Dewe Rogerson
Citigate Dewe Rogerson is one of the most respected names in communications. The company is experts in the company's fields, combining the expertise of bankers, fund managers, in-house investor relations, former journalists and creative communications professionals as well as sector and transaction specialists. The company is City-based but the company's business and perspective are international. The company serves over 500 clients from new start-ups to some of the world's largest listed companies, governments and other organisations from the company's offices in London and in the US, Europe, the Gulf and Asia.Explore more
Citigate Dewe Rogerson Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Citigate Dewe Rogerson your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Citigate Dewe Rogerson
Click to see if Citigate Dewe Rogerson had a recent Job posting/layoffs
Citigate Dewe Rogerson, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Citigate Dewe Rogerson recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Citigate Dewe Rogerson has recently received funding, and reach out quickly before it becomes old news!
Check out if Citigate Dewe Rogerson is spiking on competitors!
Funding: Get notified immidiatlly once Citigate Dewe Rogerson has new funding data
Product Launch: Get notified when Citigate Dewe Rogerson launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Citigate Dewe Rogerson
Compare insights from companies similar to Citigate Dewe Rogerson, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Citigate Dewe Rogerson is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Citigate Dewe Rogerson is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Citigate Dewe Rogerson.
Citigate Dewe Rogerson Tech Stack
A closer look at the technologies used by Citigate Dewe Rogerson
See more technologies
Citigate Dewe Rogerson News & Media
Chi-Med Announces Phase III FALUCA Trial Results for Fruquintinib in Third-Line, Advanced Non-Small Cell Lung Cancer in China
– Trial did not meet the primary endpoint of overall survival despite improvement in progression-free survival –Transgene - Positive Results from Phase 1 Clinical Trial of TG1050 in Chronic Hepatitis B Presented at the AASLD Liver Meeting 2018
STRASBOURG, France--(BUSINESS WIRE)--#HBV--Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies, announced the complete data from the Phase 1 trial evaluating the safety and immunogenicity of TG1050 in patients with chronic hepatitis B. The data have been presented at the American Association for the Study of Liver Diseases (AASLD) by Prof. Fabien Zoulim head of the Hepatology and Gastroenterology service of the CroTransgene and BioInvent Present Positive Data at the SITC, Supporting the Co-development of a Next-generation Oncolytic Virus Encoding for an Anti-CTLA-4 Antibody
LUND, Sweden and STRASBOURG, France, Nov 7, 2018 /PRNewswire/ -- BioInvent International AB (OMXS: BINV), focused on the discovery and development of novel and first-in-class immuno-regulatory antibodies to treat cancer, and Transgene (Euronext Paris: TNG), a biotech company that designs...Transgene and BioInvent Present Positive Data at the SITC, Supporting the Co-Development of a Next-Generation Oncolytic Virus Encoding for an Anti-CTLA-4 Antibody
STRASBOURG, France & LUND, Sweden--(BUSINESS WIRE)--#HBV--Regulatory News: Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies, and BioInvent International AB (OMXS: BINV), focused on the discovery and development of novel and first-in-class immuno-regulatory antibodies to treat cancer, announced they will be presenting two back-to-back posters featuring positive data supporting their ongoing collaboration to develop a novel oncolytic virus encoding for
Read more news
Top Advertising Networks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Citigate Dewe Rogerson
Sign Up For FreeTo access detailed company insights
Citigate Dewe Rogerson is one of the most respected names in communications. The company is experts in the company's fields, combining the expertise of bankers, fund managers, in-house investor relations, former journalists and creative communications professionals as well as sector and transaction specialists. The company is City-based but the com... Read More
